Schott Pharma AG KGaA (XTER:1SXP) Total Inventories : €152.4 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA Total Inventories?

Schott Pharma AG KGaA's total inventories for the quarter that ended in Dec. 2024 was €152.4 Mil. Schott Pharma AG KGaA's average total inventories from the quarter that ended in Sep. 2024 to the quarter that ended in Dec. 2024 was €146.4 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Schott Pharma AG KGaA's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was €-2.90.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Schott Pharma AG KGaA's Days Inventory for the three months ended in Dec. 2024 was 87.17.

Inventory Turnover measures how fast the company turns over its inventory within a year. Schott Pharma AG KGaA's Inventory Turnover for the quarter that ended in Dec. 2024 was 1.05.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Schott Pharma AG KGaA's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.64.

Schott Pharma AG KGaA Total Inventories Historical Data

The historical data trend for Schott Pharma AG KGaA's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Total Inventories Chart

Schott Pharma AG KGaA Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

Sep24

Total Inventories

63.22

83.52

128.94

138.94

140.45

Schott Pharma AG KGaA Quarterly Data
	Sep20	Sep21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Inventories	Get a 7-Day Free Trial								141.85	144.31	145.47	140.45	152.39

Schott Pharma AG KGaA Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Schott Pharma AG KGaA (XTER:1SXP) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Schott Pharma AG KGaA's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is

	Net-Net Working Capital Per Share (Q: Dec. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(23.727	+	0.75 * 151.43	+	0.5 * 152.387	-	648.054
-	0	-	1.989)	/	150.615
=	-2.90

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Schott Pharma AG KGaA's Days Inventory for the three months ended in Dec. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2024 )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
	=	146.416	/	153.274	*	365 / 4
	=	87.17

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Schott Pharma AG KGaA's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2024 )	/	Average Total Inventories (Q: Dec. 2024 )
	=	153.274	/	146.416
	=	1.05

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Schott Pharma AG KGaA's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	146.416	/	229.841
	=	0.64

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Schott Pharma AG KGaA Total Inventories Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Schott Pharma AG KGaA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (XTER:1SXP) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

1SXPd:UK 1SXP:Austria

Address

Hattenbergstrasse 10, Mainz, RP, DEU, 55122

Website

https://www.schott-pharma.com

Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Executives

Dr. Jens Schulte	Supervisory Board
Andreas Reisse	Board of Directors
Ann-kristin Erkens	Supervisory Board
Dr. Almuth Steinkühler	Board of Directors
Dr. Wolfgang Wienand	Supervisory Board
Peter Goldschmidt	Supervisory Board

Schott Pharma AG KGaA Headlines

No Headlines